INTRODUCTION {#sec1-1}
============

Atrial fibrillation (AF) is the most common arrhythmia after open heart surgery that can lead to early morbidity and mortality following operation. Predisposing factors of post-operative AF include: Age, male sex, BMI \>30, atrial dilatation, long-term aortic cross clamp, post-operative pericarditis, pre-operative leukocytosis, and increase in plasma level of inflammatory markers.\[[@ref1][@ref2]\] Post-operative atrial fibrillation (POAF) may increase heart failure, stroke, pulmonary edema, kidney and respiratory disorders, longer stay in ICU and hospital, as well as increase in therapy costs.\[[@ref3][@ref4]\]

Valvular heart diseases (VHD) account for 10-20% of all cardiac surgical procedures in the world. Inflammatory response of the immune system is one of the most important pathogenesis of VHD.\[[@ref5][@ref6]\] Mitral stenosis (MS) is a structural abnormality of the mitral valve apparatus that can result from previous rheumatic fever. Non-rheumatic mitral stenosis may be due to congenital mitral stenosis, malignant carcinoid disease, etc.

This study was designed to compare the incidence of atrial fibrillation and early outcomes following mitral valve replacement in patients with rheumatic or non-rheumatic mitral stenosis, in Afshar Cardiovascular Center, Yazd, Iran.

MATERIALS AND METHODS {#sec1-2}
=====================

Our cross-sectional study was approved by ethics committee in our university. Patients who were candidates for mitral valve surgery were enrolled in the study which lasted from 15 November 2010 to 15 November 2011 (one year). After obtaining consent forms, the patients underwent mitral valve replacement. All of the operations were performed by one senior surgeon. Fifty patients suffered from rheumatic mitral stenosis who were candidates for mitral valve surgery were enrolled in this study. Pre-operative tests such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), complete blood count (CBC), urine analysis (UA), anti-nuclear antibody (ANA), anti-phospholipid (APL-IgM, IgG), anti-neutrophil cytoplasmic antibody (ANCA-c, p), rheumatoid factor (RF) were performed on participants' samples. The type of mitral stenosis, rheumatic or non-rheumatic was determined clinically.

The demographic variables and early post-operative complications such as infection, bleeding, vomiting, renal and respiratory dysfunction, ICU and hospital stay were recorded. All patients underwent holter monitoring after being out of ICU at the time of discharge. Our data were analyzed by SPSS 15 software. We used ANOVA, Chi-square, and Fisher exact test for quantitative and qualitative variables.

RESULTS {#sec1-3}
=======

Fifty-seven cases (57%) were male and 43 cases (43%) were female. Of all the participants, AF was observed in 14 patients (14%); 9 of whom were male and 5 were female. There was no significant relationship between sex and AF after surgery (*P* = 0.84). POAF occurred in 14 cases (14%); 3 cases (6%) related to non-rheumatic mitral stenosis group, and 11 cases (22%) related to the rheumatic mitral stenosis group \[[Table 1](#T1){ref-type="table"}\]. There was a significant relationship between incidence of AF and type of mitral stenosis (*P* = 0.02).
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Post-operative atrial fibrilation and early complications after operation in both groups
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The mean duration of AF was 1135 ± 1060 min, which in the non-rheumatic MS group was 890 ± 1084 min and in the rheumatic MS group was 1170 ± 1056 min (*P* = 0.62). Moreover, the duration of AF which totally was 2.7 ± 1.9 days; in the rheumatic MS group, it was 2.33 ± 1.8 days and in the non-rheumatic MS group, it was 2.86 ± 2.01 days (*P* = 0.51). This data shows that duration and frequency of recurrence of AF have no significant relationship with rheumatic or non-rheumatic MS.

Early complications after operation were compared between two groups in [Table 1](#T1){ref-type="table"}. According to [Table 1](#T1){ref-type="table"}, post-MVR bleeding was lower in rheumatic MS than in non-rheumatic MS (*P* = 0.56). Renal dysfunction after MVR was higher in rheumatic MS than in non-rheumatic MS (*P* = 0.02). ICU stay in non-rheumatic MS group was 3.6 ± 1.80 days, while for another group was 3.4 ± 1.26 days. Also, hospital stay duration was 6.5 ± 2.2 days for the non-rheumatic MS group in comparison to the rheumatic MS group that was 8.84 ± 2.06 days. Therefore, rheumatic MS can increase hospitalization stay but cannot prolong ICU stay compared to non-rheumatic MS. Early mortality occurred in 2 cases (2%) in hospital after the operation; 1 case (1%) in the rheumatic MS group and 1 case (1%) in the non-rheumatic MS group. There was no relationship between type of mitral stenosis (rheumatic or non-rheumatic) and early mortality after mitral valve replacement.

DISCUSSION {#sec1-4}
==========

Atrial fibrillation (AF) is the most common arrhythmia following open heart surgery and is the most important cause of morbidity and mortality in hospitalization stay. Its incidence is related to the patient\'s characteristics and type of surgical operation. Non-congenital and valvular heart disease patients who undergo open heart surgery usually do not have a history of inflammation. However, inflammatory conditions can occur in these patients such as rheumatoid arthritis, anti-phospholipid syndrome, lupus or connective tissue disease.\[[@ref1]--[@ref3]\]

The report of incidence of post-operative AF in the literature is 20-50% after cardiovascular surgery and occurs two or three days post-operatively.\[[@ref3][@ref4]\] Horskotte *et al*. reported that the underlying pathology for patients waiting for mitral valve replacement was 77% rheumatic in their study of 1051 patients.\[[@ref7]\] Guiherme *et al*. reported that the most serious complication of patients with valvular heart disease was rheumatic fever in 30-45%.\[[@ref8]\]

Our findings show that duration and frequency of recurrence of AF have no significant relationship with rheumatic or non-rheumatic MS, but there was a significant relationship between incidence of AF and type of mitral stenosis. In our study, post-MVR bleeding was lower in rheumatic MS than in non-rheumatic MS; however, there was no significant difference between two groups regarding bleeding. Renal dysfunction after MVR was higher in rheumatic MS than in non-rheumatic MS. Other complications after surgery such as gastrointestinal (GI) and respiratory dysfunction, nausea and vomiting, loss of appetite etc., have no significant differences in both groups.

A study conducted by Lindhardsen *et al*. indicated the rheumatoid arthritis increased the incidence of atrial fibrillation and stroke. They believed that the increasing incidence of atrial fibrillation in rheumatoid arthritis can suggest that atrial fibrillation is relevant in the cardiovascular risk assessment of patients with rheumatoid arthritis.\[[@ref9]\] A study carried out by Ozaydin *et al*. reported that factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis are included high sensitivity to C-reactive protein, N-terminal of brain natriuretic peptide precursor and left atrial diameter.\[[@ref6]\] Akram *et al*. suggested that non-rheumatic mitral stenosis is more frequent than is assumed and is associated with risk factors for coronary artery disease.\[[@ref10]\]

In our study, there was no relationship between type of mitral stenosis (rheumatic or non-rheumatic) and early mortality after mitral valve replacement. LaPar *et al*. suggested that patients undergoing surgical mitral valve replacement have low mortality. Major adverse event\'s rate was significantly due to post-operative atrial fibrillation.\[[@ref11]\] Kim *et al*. reported that the long-term outcome of patients with symptomatic mitral stenosis after previous percutaneous mitral balloon valvotomy (PMV) was more favorable after mitral valve replacement than after repeated percutaneous mitral balloon valvotomy.\[[@ref12]\]

We conclude from this study that the type of mitral stenosis (rheumatic or non-rheumatic MS) had effect on post-operative outcomes, especially incidence of atrial fibrillation and some complications after mitral valve replacement. We recommend that specifying the etiology of mitral stenosis can help cardiac surgeons and may prevent mortality and morbidity of patients undergoing mitral valve replacement.

In conclusion, the long-term outcome of patients with symptomatic MS after previous PMV was more favorable after MVR than after repeated PMV. These data suggest that MVR may be preferred mode of therapy in patients with unfavorable valve morphologic characteristics and no co-morbidities.
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